Author:
Meira Jorge,Madeira Carolina,Falcão-Reis Fernando,Figueira Luís
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16.
2. Goldhardt R, Rosen BS. Uveitic macular edema: treatment update. Curr Ophthalmol Rep. 2016;4(1):30–7.
3. National Institute for Health and Care Excellence (NICE) 2018. Final scope for the appraisal of fluocinolone acetonide ocular implant for treating recurrent non-infectious uveitis.
https://www.nice.org.uk/guidance/gid-ta10368/documents/final-scope
. Accessed 4 Jul 2019
4. Durani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159–62.
5. Koronis S, Stavrakas P, Balidis M, Kozeis N, Tranos PG. Update in treatment of uveitic macular edema. Drug Des Devel Ther. 2019;13:667–80.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献